Literature DB >> 2357153

Magnetic resonance imaging in Parkinson's disease.

S J Huber1, D W Chakeres, G W Paulson, R Khanna.   

Abstract

Magnetic resonance imaging was utilized to examine changes in the pars compacta associated with Parkinson's disease. We found a reduction in average width of the pars compacta in advanced- but not early-stage patients. Conversely, a significant difference in width (right minus left) was observed in early- but not late-stage patients. Width asymmetry may be a sensitive magnetic resonance imaging indicator for the early detection of Parkinson's disease when there is a predominance of unilateral clinical symptoms.

Entities:  

Mesh：

Year:  1990        PMID： 2357153     DOI： 10.1001/archneur.1990.00530070023006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


  10 in total

1.  The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings.

Authors:  Hirobumi Oikawa; Makoto Sasaki; Yoshiharu Tamakawa; Shigeru Ehara; Koujiro Tohyama
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

Review 2.  Techniques for brain imaging in vivo.

Authors:  Monica Garcia-Alloza; Brian J Bacskai
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

3.  Magnetization transfer changes of grey and white matter in Parkinson's disease.

Authors:  N Tambasco; G P Pelliccioli; P Chiarini; G E Montanari; F Leone; M L Mancini; M Paciaroni; V Gallai
Journal:  Neuroradiology       Date:  2003-02-21       Impact factor: 2.804

4.  Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism.

Authors:  Deepak Gupta; Jitender Saini; Chandrasekharan Kesavadas; P Sankara Sarma; Asha Kishore
Journal:  Neuroradiology       Date:  2010-04-01       Impact factor: 2.804

Review 5.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

6.  Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging.

Authors:  M Adachi; T Hosoya; T Haku; K Yamaguchi; T Kawanami
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

7.  New MRI Biomarkers Advance the Characterization of Parkinson Disease.

Authors:  David A Ziegler; Suzanne Corkin
Journal:  Eur Neurol Rev       Date:  2013

8.  The regional distribution of T2-relaxation times in MR images of the substantia nigra and crus cerebri.

Authors:  Constantin Mänz; Jana Godau; Daniela Berg; Benjamin Bender; Ulrike Ernemann; Uwe Klose
Journal:  Neuroradiology       Date:  2009-10-27       Impact factor: 2.804

9.  Computed tomography, magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in multiple system atrophy and pure autonomic failure.

Authors:  M J Fulham; R M Dubinsky; R J Polinsky; R A Brooks; R T Brown; M T Curras; S Baser; M Hallett; G Di Chiro
Journal:  Clin Auton Res       Date:  1991-03       Impact factor: 4.435

10.  Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria.

Authors:  A Albanese; C Colosimo; A R Bentivoglio; R Fenici; G Melillo; C Colosimo; P Tonali
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.